Howe & Rusling’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $974K | Sell |
34,700
-6,368
| -16% | -$170K | 0.06% | 132 |
|
|
2025
Q4 | $1.02M | Buy |
41,068
+10,488
| +34% | +$264K | 0.07% | 124 |
|
|
2025
Q3 | $779K | Buy |
30,580
+981
| +3% | +$24.2K | 0.05% | 143 |
|
|
2025
Q2 | $717K | Buy |
29,599
+799
| +3% | +$18.6K | 0.05% | 147 |
|
|
2025
Q1 | $730K | Buy |
28,800
+2,345
| +9% | +$61.4K | 0.06% | 137 |
|
|
2024
Q4 | $702K | Sell |
26,455
-8,477
| -24% | -$230K | 0.06% | 127 |
|
|
2024
Q3 | $1.01M | Sell |
34,932
-4,534
| -11% | -$132K | 0.09% | 114 |
|
|
2024
Q2 | $1.1M | Buy |
39,466
+531
| +1% | +$14.6K | 0.1% | 109 |
|
|
2024
Q1 | $1.08M | Sell |
38,935
-13,480
| -26% | -$374K | 0.1% | 115 |
|
|
2023
Q4 | $1.51M | Sell |
52,415
-10,010
| -16% | -$303K | 0.16% | 102 |
|
|
2023
Q3 | $2.07M | Sell |
62,425
-4,537
| -7% | -$160K | 0.24% | 91 |
|
|
2023
Q2 | $2.46M | Sell |
66,962
-2,199
| -3% | -$85.6K | 0.27% | 85 |
|
|
2023
Q1 | $2.82M | Sell |
69,161
-4,433
| -6% | -$191K | 0.34% | 71 |
|
|
2022
Q4 | $3.77M | Sell |
73,594
-4,114
| -5% | -$197K | 0.47% | 62 |
|
|
2022
Q3 | $3.4M | Buy |
77,708
+5,133
| +7% | +$249K | 0.45% | 63 |
|
|
2022
Q2 | $3.81M | Buy |
72,575
+23,039
| +47% | +$1.17M | 0.48% | 64 |
|
|
2022
Q1 | $2.56M | Sell |
49,536
-15,128
| -23% | -$785K | 0.3% | 79 |
|
|
2021
Q4 | $3.82M | Sell |
64,664
-45,341
| -41% | -$2.25M | 0.45% | 64 |
|
|
2021
Q3 | $4.73M | Sell |
110,005
-258,951
| -70% | -$11.5M | 0.59% | 58 |
|
|
2021
Q2 | $14.4M | Sell |
368,956
-37,768
| -9% | -$1.47M | 1.82% | 12 |
|
|
2021
Q1 | $14.7M | Sell |
406,724
-11,960
| -3% | -$425K | 2% | 11 |
|
|
2020
Q4 | $15.4M | Sell |
418,684
-24,877
| -6% | -$912K | 2.34% | 8 |
|
|
2020
Q3 | $15.4M | Sell |
443,561
-6,149
| -1% | -$216K | 2.65% | 7 |
|
|
2020
Q2 | $14M | Buy |
449,710
+138,291
| +44% | +$4.7M | 2.57% | 7 |
|
|
2020
Q1 | $9.64M | Buy |
311,419
+279,697
| +882% | +$9.53M | 2.08% | 10 |
|
|
2019
Q4 | $1.18M | Sell |
31,722
-41,531
| -57% | -$1.48M | 0.2% | 93 |
|
|
2019
Q3 | $2.5M | Sell |
73,253
-1,659
| -2% | -$60.3K | 0.44% | 63 |
|
|
2019
Q2 | $3.08M | Sell |
74,912
-29,545
| -28% | -$1.17M | 0.53% | 55 |
|
|
2019
Q1 | $4.21M | Buy |
104,457
+24,074
| +30% | +$964K | 0.73% | 45 |
|
|
2018
Q4 | $3.33M | Buy |
80,383
+961
| +1% | +$39.9K | 0.7% | 46 |
|
|
2018
Q3 | $3.32M | Sell |
79,422
-287,496
| -78% | -$11.1M | 0.55% | 53 |
|
|
2018
Q2 | $12.6M | Sell |
366,918
-3,155
| -0.9% | -$108K | 2.29% | 11 |
|
|
2018
Q1 | $12.5M | Sell |
370,073
-9,849
| -3% | -$339K | 2.26% | 8 |
|
|
2017
Q4 | $13.1M | Sell |
379,922
-7,372
| -2% | -$251K | 2.37% | 5 |
|
|
2017
Q3 | $13.1M | Sell |
387,294
-2,610
| -0.7% | -$83.9K | 2.43% | 4 |
|
|
2017
Q2 | $12.4M | Buy |
389,904
+6,774
| +2% | +$214K | 2.53% | 4 |
|
|
2017
Q1 | $12.4M | Buy |
383,130
+25,759
| +7% | +$812K | 2.49% | 4 |
|
|
2016
Q4 | $11M | Sell |
357,371
-29,232
| -8% | -$892K | 2.42% | 6 |
|
|
2016
Q3 | $12.4M | Buy |
386,603
+30,069
| +8% | +$1.01M | 2.68% | 3 |
|
|
2016
Q2 | $11.9M | Buy |
356,534
+118,703
| +50% | +$3.79M | 2.62% | 2 |
|
|
2016
Q1 | $6.69M | Buy |
237,831
+154,797
| +186% | +$4.42M | 1.51% | 14 |
|
|
2015
Q4 | $2.54M | Sell |
83,034
-1,497
| -2% | -$47.1K | 0.58% | 63 |
|
|
2015
Q3 | $2.52M | Sell |
84,531
-572
| -0.7% | -$18.3K | 0.63% | 60 |
|
|
2015
Q2 | $2.71M | Sell |
85,103
-1,559
| -2% | -$50.8K | 0.59% | 61 |
|
|
2015
Q1 | $2.86M | Sell |
86,662
-6,610
| -7% | -$210K | 0.64% | 57 |
|
|
2014
Q4 | $2.76M | Sell |
93,272
-1,938
| -2% | -$55.6K | 0.66% | 52 |
|
|
2014
Q3 | $2.67M | Sell |
95,210
-1,660
| -2% | -$46.6K | 0.62% | 55 |
|
|
2014
Q2 | $2.73M | Sell |
96,870
-31,527
| -25% | -$899K | 0.61% | 55 |
|
|
2014
Q1 | $3.91M | Buy |
128,397
+31,923
| +33% | +$952K | 0.96% | 39 |
|
|
2013
Q4 | $2.8M | Buy |
96,474
+12,708
| +15% | +$370K | 0.71% | 46 |
|
|
2013
Q3 | $2.29M | Sell |
83,766
-133,788
| -61% | -$3.64M | 0.84% | 46 |
|
|
2013
Q2 | $5.78M | Buy |
+217,554
| New | +$6.01M | 1.61% | 18 |
|
Other funds holding PFE
VCM
VPM
Howe & Rusling's PFE Position: Q1 2026 in Review
Howe & Rusling reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $170K and leaving 34,700 shares worth $974K. The position accounts for 0.06% of the portfolio, ranked #132.
Howe & Rusling first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.4M in Q3 2020. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Howe & Rusling held 34,700 shares of Pfizer worth $974K as of Q1 2026.
- Howe & Rusling sold 6,368 Pfizer shares in Q1 2026, an estimated $170K.
- Pfizer made up 0.06% of Howe & Rusling's portfolio in Q1 2026, its #132 holding.
- Howe & Rusling first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Howe & Rusling's Pfizer position peaked at $15.4M in Q3 2020.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.